• Something wrong with this record ?

Sensitization to Molecular Components in 104 Atopic Dermatitis Patients in Relation to Subgroups of Patients Suffering from Bronchial Asthma and Allergic Rhinitis

R. Vaňková, J. Čelakovská, J. Bukač, I. Krčmová, J. Krejsek, C. Andrýs

. 2020 ; 63 (4) : 164-175.

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21023702

Grant support
PROGRES Q40/10 Univerzita Karlova v Praze

BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease. The progression from AD to bronchial asthma (AB) and allergic rhinitis (AR) is called atopic march. The aim of this study was to evaluate the difference in the sensitization to molecular components in patients suffering from AD in relation to subgroups of patients with AR and AB. MATERIAL AND METHODS: The complete dermatological and allergological examinations were performed. Specific IgE antibodies against 112 molecular components were measured with the multiplex ImmnoCAP ISAC test. RESULTS: Altogether 104 atopic dermatitis patients (50 men, 54 women) at the average age 40.1 years were examined. The sensitization to molecular components was confirmed in 93.3% of patients. The sensitization to components of mites, grasses, trees, animals, moulds, and shrimps was significantly more frequent in patients with severe form of AD and the sensitization to components of grasses, trees, and moulds was significantly higher in subgroup of patients with AB. In subgroup of patients suffering from AR the higher occurrence of pollen-derived and pollen-food derived PR-10 proteins, grasses, mites, and animals was observed also. CONCLUSIONS: We have confirmed the significant differences in the sensitization to molecular components in patients suffering from severe form of AD, and in subgroups of patients suffering from AB and AR. These molecular components may play the important role in the consecutive development of different allergy pathologies called atopic march.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21023702
003      
CZ-PrNML
005      
20211104134122.0
007      
ta
008      
211005s2020 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2020.59 $2 doi
035    __
$a (PubMed)33355077
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Vaňková, Radka $7 xx0255512 $u Department of Clinical Immunology and Allergology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic
245    10
$a Sensitization to Molecular Components in 104 Atopic Dermatitis Patients in Relation to Subgroups of Patients Suffering from Bronchial Asthma and Allergic Rhinitis / $c R. Vaňková, J. Čelakovská, J. Bukač, I. Krčmová, J. Krejsek, C. Andrýs
504    __
$a Literatura
520    9_
$a BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease. The progression from AD to bronchial asthma (AB) and allergic rhinitis (AR) is called atopic march. The aim of this study was to evaluate the difference in the sensitization to molecular components in patients suffering from AD in relation to subgroups of patients with AR and AB. MATERIAL AND METHODS: The complete dermatological and allergological examinations were performed. Specific IgE antibodies against 112 molecular components were measured with the multiplex ImmnoCAP ISAC test. RESULTS: Altogether 104 atopic dermatitis patients (50 men, 54 women) at the average age 40.1 years were examined. The sensitization to molecular components was confirmed in 93.3% of patients. The sensitization to components of mites, grasses, trees, animals, moulds, and shrimps was significantly more frequent in patients with severe form of AD and the sensitization to components of grasses, trees, and moulds was significantly higher in subgroup of patients with AB. In subgroup of patients suffering from AR the higher occurrence of pollen-derived and pollen-food derived PR-10 proteins, grasses, mites, and animals was observed also. CONCLUSIONS: We have confirmed the significant differences in the sensitization to molecular components in patients suffering from severe form of AD, and in subgroups of patients suffering from AB and AR. These molecular components may play the important role in the consecutive development of different allergy pathologies called atopic march.
650    _2
$a dospělí $7 D000328
650    _2
$a alergeny $x imunologie $7 D000485
650    _2
$a bronchiální astma $x imunologie $7 D001249
650    _2
$a atopická dermatitida $x imunologie $7 D003876
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin E $x imunologie $7 D007073
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a alergická rýma $x imunologie $7 D065631
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a časopisecké články $7 D016428
700    1_
$a Čelakovská, Jarmila $7 xx0146633 $u Department of Dermatology and Venereology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic
700    1_
$a Bukač, Josef, $d 1947- $7 hka0110782 $u Department of Medical Biophysic, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic
700    1_
$a Krčmová, Irena, $d 1957- $7 mzk2006368125 $u Department of Clinical Immunology and Allergology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic
700    1_
$a Krejsek, Jan, $d 1958- $7 nlk19990073429 $u Department of Clinical Immunology and Allergology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic
700    1_
$a Andrýs, Ctirad, $d 1962- $7 mzk2008430528 $u Department of Clinical Immunology and Allergology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1805-9694 $g Roč. 63, č. 4 (2020), s. 164-175
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33355077 $y Pubmed
910    __
$a ABA008 $b A 3077 $c 1072 $y p $z 0
990    __
$a 20211005 $b ABA008
991    __
$a 20211008105943 $b ABA008
999    __
$a ok $b bmc $g 1718890 $s 1144196
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 63 $c 4 $d 164-175 $i 1805-9694 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
GRA    __
$a PROGRES Q40/10 $p Univerzita Karlova v Praze
LZP    __
$b NLK118 $a Pubmed-20211005

Find record

Citation metrics

Archiving options